An editorial about the PURCH program at UMass Medical School’s satellite campus at Baystate Health examines ways the program will benefit the health of the region’s population.
First-year PURCH students Betsy McGovern, Prithwijit Roychowdhury, Kathryn Norman and Colton Conrad; Associate Professor and Chief Education Officer and Senior Associate Dean for Education at UMass Medical School-Baystate Kevin T. Hinchey, MD, FACP; and Assistant Professor and Assistant Dean for Education at UMass Medical School-Baystate Rebecca D. Blanchard, PhD, MEd, are quoted in a story about the UMass Medical School PURCH program located at its satellite campus at Baystate Health.
Iranian native Adel Bozorgzadeh, MD, professor of medicine and chief of transplant surgery, comments on the current protests in Iran.
Raffi Van Aroian, PhD, professor of molecular medicine, and Mark Klempner, MD, executive vice chancellor for MassBiologics of UMass Medical School and professor of medicine, discuss efforts at UMMS and MBL to develop new treatments for diseases such as hookworms and diphtheria that plague the developing world.
Stephenie Lemon, PhD, professor of medicine, is a principal investigator on an $8.75 million grant from the National Institutes of Health National Center for Advancing Translational Sciences to demonstrate the feasibility of community–academic partnerships to provide innovations in information sharing and systems implementation that will translate into reductions in health disparities for vulnerable patients facing any disease.
Darwin’s Dogs, a project led by Elinor Karlsson, PhD, assistant professor of molecular medicine, collects canine DNA with the hope of using the information as a basis for studies of obsessive compulsive disorder and behavioral conditions.
Judson A. Brewer, MD, PhD, associate professor of medicine and creator of the Unwinding Anxiety mindfulness app, talks about using mindfulness to disassociate our thoughts from certain behaviors.
Robert M. Kotin, PhD, professor of microbiology & physiological systems and co-founder of Generation Bio, is quoted in a story about the start-up’s lipid nanoparticle platform that will allow it to offer the first genetic medicines that can be titrated to a particular dose—and redosed if necessary—like a conventional drug, and avoid the pitfalls of viral gene therapies such as generating immune reactions.
An article about chronic absenteeism at the Worcester Public School’s reference’s UMass Medical School’s help with an innovative program implemented over the summer to bring laundry machines to schools to combat the lack of clean clothes faced by some students.
Jonathan Kay, MD, the Timothy S. and Elaine L. Peterson Chair in Rheumatology and professor of medicine, talks about treating inflammatory arthritis without using opioids.
Richard Friedberg, MD, chair and professor of pathology at UMMS-Baystate, cautions that new precision medical treatments reliant on patient samples need to be validated before being used in clinical settings.